Skip to content
About Us
About Healthlead
Business Overview
Vision and Mission
Business Structure
Corporate Governance
Board and Committees
Board of Directors
Audit Committee
Executive Committee
Awards and Recognitions
Awards and Recognitions
Our Pharmacies
Store Locator
Pharmax
iCare
Super Drug
Investor Relations
Investor Overview
Form 56-1 One Report
Prospectus
HL Snapshot
Financial Information
Performance Highlights
Financial Statements
Management Discussion and Analysis
MD&A
Stock Information
Stock Quote
Investment Calculator
SET Announcements
Presentations
Shareholder Information
Major Shareholders
Shareholder Meetings
Dividend Payment History
Investor Calendar
Contact IR →
Sustainability
News & Media
News
Health Articles
Contact Us
ไทย
Contact Us
Home
›
Investor Relations
›
Management Discussion and Analysis
INVESTOR RELATIONS
Management Discussion and Analysis
Management Discussion and Analysis Year 2026
Q2/2026
View Online
Download
Q1/2026
View Online
Download
Management Discussion and Analysis Year 2025
FY 2025
View Online
Download
View Online
Download
Q3/2025
View Online
Download
View Online
Download
Management Discussion and Analysis Year 2024
FY 2024
View Online
Download
View Online
Download
Q3/2024
View Online
Download
View Online
Download
Management Discussion and Analysis Year 2023
FY 2023
View Online
Download
View Online
Download
Q3/2023
View Online
Download
View Online
Download
Management Discussion and Analysis Year 2022
FY 2022
View Online
Download
View Online
Download
Q3/2022
View Online
Download
View Online
Download
Management Discussion and Analysis Year 2021
FY 2021
View Online
Download
Q3/2021
View Online
Download
